BWAY News and Press, BrainsWay Ltd. From 01/10/24

BURLINGTON, Mass. and JERUSALEM, Jan. 10, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will be ...

2024-01-08 23:32:32 ET Summary BrainsWay has achieved a successful turnaround with positive adjusted EBITDA and cash flow in Q3/23. The company offers advanced TMS therapy devices and has numerous patents. There are plenty of growth drivers from reimbursement, new conditions, ...

2023-12-29 10:00:03 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Healthcare and utilities could perform better in 2024 - analyst Arcus, Bristol-Myers, ...

BURLINGTON, Mass. and JERUSALEM, Dec. 19, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced increased collab...

BrainsWay Ltd. (NASDAQ: BWAY) is the focus of IBN's latest stock spotlight. The company's shares have moved 3.64% on the day to $3.27. Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally...

BURLINGTON, Mass. and JERUSALEM, Dec. 07, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced expanded availab...

2023-11-30 20:32:31 ET Summary BrainsWay's stock grew 300%, driven by a 60% year-over-year revenue increase and Deep TMS technology success, achieving positive cash flow. Deep TMS faces challenges: clinical variability, practicality issues, market competition, evolving payer cover...

BrainsWay Ltd. (NASDAQ: BWAY) is the focus of IBN's latest stock spotlight. The company's shares have moved 3.64% on the day to $3.27. Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally...

2023-11-27 13:27:19 ET More on Markets BMO Capital Markets sets base-case S&P 500 target of 5,100 for 2024 Rate cuts, S&P upside and oil prices among BofA's key themes for 2024 VanEck highlights mid-caps as a potential sweet spot for investors For fur...

BrainsWay Ltd. (NASDAQ: BWAY) is the focus of IBN's latest stock spotlight. The company's shares have moved 3.64% on the day to $3.27. Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally...